West Pharmaceutical Services, Inc. (WST)
NYSE · Health Care · market cap 22.81B
Share price
$366.60
At the last nightly close
Intrinsic value
$156.09
Range $136.92 – $185.42 — the conservative figure is the low end.
Margin of safety
-57.4%
($156.09 − $366.60) ÷ $366.60
EV / EBIT
109.0
On the median operating profit of 15 fiscal years through 2025.
How these numbers are computed
The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above is the low end of what they agree on.
The frame gives no credit for growth. A company that compounds will therefore read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.
The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.
Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-09-03.
Key metrics
Market position
Annual financials
| Period | Revenue | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|
| 2025-FY | 3.07B | 636.1M | 493.7M | 6.83 | 468.9M |
| 2024-FY | 2.89B | 590.9M | 492.7M | 6.75 | 276.4M |
| 2023-FY | 2.95B | 707.4M | 593.4M | 7.98 | 414.5M |
| 2022-FY | 2.89B | 760.8M | 585.9M | 7.87 | 439.4M |
| 2021-FY | 2.83B | 752.3M | 661.8M | 8.67 | 330.6M |
Filed figures from SEC EDGAR, in the reporting currency.
Next earnings
Recent news
- The Top 5 Analyst Questions From West Pharmaceutical Services’s Q1 Earnings Call - StockStorystockstory.org
- WST Earnings: Latest Report, Earnings Call & Financialspublic.com
- West Pharmaceutical Services (WST) Earnings Date and Reports 2026marketbeat.com
- West Pharmaceutical Services (WST) Stock Analysis: Riding A 14.63% Potential Upside With Strong Analyst Confidencedirectorstalkinterviews.com
- West Pharmaceutical Services (NYSE:WST) - Stock Analysissimplywall.st
Headlines link to their source. Sperio does not republish article text.
The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on WST.
Run the board on WST10 free analyses · no signup, no card
This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.